Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

This Is What I'd Do With Pfizer Stock Right Now

The pharmaceutical stock is struggling, but its dividend can be highly valuable to income investors.

This Is What I'd Do With Pfizer Stock Right Now

Published September 7, 2026 · Category: Finance

Overview

Investing in a top pharmaceutical company such as Pfizer (NYSE:PFE) might seem like a good long-term hold. Unfortunately, that hasn't been the case in recent years. In the past five years, it has lost close to 40% of its value.

Many investors are torn about whether it's a good value buy or just a trap, given the question marks about its long-term future. Here's why I think the stock could be a great buy-and-hold investment right now.

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.